Clinical Trial Update: An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study in healthy volunteers evaluating the pharmacokinetics of GSK961081 with fluticasone propionate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)
• GSK961081

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED